POLB — Poolbeg Pharma Share News
0.000.00%
Last trade - 00:00Voluntary Delisting from OTCQB Market
Notification of Major Holdings
Annual Report & AGM Notice
UK's Poolbeg Pharma gains on grant of US patent for immunomodulator drugs
Polb 001 Patent Granted In United States
Significant POLB 001 Patent Granted in USA
Brief: Poolbeg Pharma Entered Into Exclusive 12-Month Option Agreement With Silk Road Therapeutics
Results for the year ended 31 December 2023
Brief: Poolbeg Pharma PLC Gets Notice Of Allowance For Significant POLB 001 Patent In United States
POLB 001 US Patent Update
Director/PDMR Shareholding
Director Share Purchase
Brief: Poolbeg Pharma Cathal Friel Currently Is Assuming Role Of Executive Chairman At Company Effective Immediately
Board Role Change and Launch of EIP
Brief: Poolbeg Pharma Says Further Data Showed Polb001's Potential In Cancer CRS
RSV AI Drug Candidate Analysis Update
Brief: Poolbeg Pharma Says Patrick Ashe Will Step Down From Board At End Of Nov
Directorate Change
Brief: Poolbeg Pharma Says Japanese Patent Office Notified Co Of Official Decision To Grant Poolbeg's Immunomodulator II Patent Application